In an assessment of TCGA glioma and the Chinese Glioma Genomic Atlas (CGGA) data, overexpression of SLAMF8 was associated with progression, higher grade glioma, and it was a biomarker for the mesenchymal subtype. Here, SLAMF8 is linked to glioma.